Identification of tissue transglutaminase as the autoantigen of celiac disease

Nature Medicine

Volumn 3, Issue 7, 1997, Pages 797-801

  Dieterich, Walburga ^a   Ehnis, Tobias ^a   Bauer, Michael ^a   Donner, Peter ^b   Volta, Umberto ^b   Riecken, Ernst Otto ^a   Schuppan, Detlef ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; GLIADIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANTIGEN PURIFICATION; ANTIGEN RECOGNITION; ARTICLE; CANCER RISK; CELIAC DISEASE; HUMAN; HUMAN CELL; INTESTINE CRYPT; INTESTINE VILLUS; PRIORITY JOURNAL; T CELL LYMPHOMA;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CELIAC DISEASE; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRONECTINS; GLIADIN; GUINEA PIGS; HAPLORHINI; HUMANS; IMMUNOGLOBULIN A; SUBSTRATE SPECIFICITY; TRANSGLUTAMINASES; TUMOR CELLS, CULTURED;

TRITICUM AESTIVUM;

EID: 0030838044     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0797-797     Document Type: Article

References (37)

1. Trier, J.S. Celiac sprue. N. Engl. J. Med. 325, 1709-1719 (1991).
2. Holmes, G.K.T., Prior, P., Lane, M.R., Pope, D. & Allan, R.N. Malignancy in coeliac disease - effect of a gluten-free diet. Gut 30, 333-338 (1989).
3. Logan, R.F.A., Rifkin, E.A., Turner, I.D. & Ferguson, A. Mortality in celiac disease. Gastroenterology 97, 265-271 (1989).
4. Marsh, M.N. Gluten, major histocompatibility complex, and the small intestine: A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 102, 330-354 (1992).
5. Sturgess, R. et al. Wheat peptide challenge in coeliac disease. Lancet 343, 758-761 (1994).
6. Ferguson, A., Arranz, E. & Kingstone, K. Clinical and pathological spectrum of coeliac disease. in: Malignancy and Chronic Inflammation in the Gastrointestinal Tract - New Concepts. (eds. Riecken, E.O., Zeitz, M., Stallmach, A. & Heise, W.) 51-63 (Kluwer Acad. Press, Dordrecht, the Netherlands, 1995).
7. Walker-Smith, J.A., Guandalini, S., Schmitz, J., Shmerling, D.H. & Visakorpi, J.K. Revised criteria for diagnosis of coeliac disease. Arch. Dis. Child. 65, 909-911 (1990).
8. Bürgin-Wolff, A. et al. Antigliadin and antiendomysium antibody determination for coeliac disease. Arch. Dis. Child. 66, 941-947 (1991).
9. Volta, U., Molinaro, N., Fusconi, M., Cassani, F. & Blanchi, F.B. IgA antiendomysial antibody test: A step forward in celiac disease screening. Dig. Dis. Sci. 36, 752-756 (1991).
10. Mylotte, A., Egan-Mitchell, B., McCarthy, C.F. & McNicholl, B. Incidence of coeliac disease in the west of Ireland. Br. Med. J. 1, 703-705 (1973).
11. Greco, L., Mäki, M., Di Donato, F. & Visakorpi, J.K. Epidemiology of coeliac disease in Europe and the Mediterranean Area. in: Common Food Intolerances, Vol. 1, Epidemiology of Coeliac Disease. (eds. Auricchio, S. & Visakorpi, J.K.) 25-44 (Karger, Basel, Switzerland, 1992).
12. Sandforth, F. et al. Inzidenz der einheimischen Sprue/Zöliakie in Berlin (West): Eine prospektive Untersuchung mit kurzer Falldiskussion. Z. Gastroenterol. 29, 327-332 (1991).
13. Catassi, C. et al. Coeliac disease in the year 2000: Exploring the iceberg. Lancet 343, 200-203 (1994).
14. Not, T. et al. Endomysium antibodies in blood donors predicts a high prevalence of celiac disease in the USA. Gastroenterology 110, A351 (1996).
15. Lerner, A., Kumar, V. & Iancu, T.C. Immunological diagnosis of childhood coeliac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies. Clin. Exp. Immunol. 95, 78-82 (1994).
16. Picarelli, A. et al. Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. Lancet 348, 1065-1067 (1996).
17. Mäki, M. Coeliac disease and autoimmunity due to unmasking of cryptic epitopes? Lancet 348, 1046-1047 (1996)
18. Cordell, J.L. et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes. J. Histochem. Cytochem. 32, 219-229 (1984).
19. Gentile, V. J. et al. Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J. Biol. Chem. 266, 478-483 (1991).
20. Barsigian, C., Stern, A.M. & Martinez, J. Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. J. Biol. Chem. 266, 22501-22509 (1991).
21. Greenberg, C.S., Birckbichler, P.J. & Rice, R.H. Transglutaminases: Multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 5, 3071-3077 (1991).
22. Upchurch, H.F., Conway, E., Patterson, M.K. & Maxwell, M.D. Localization of cellular transglutaminase on the extracellular matrix after wounding: Characteristics of the matrix bound enzyme. J. Cell Physiol. 149, 375-382 (1991).
23. Martinez, J., Chalupowicz, D.G., Roush, R.K., Sheth, A. & Barsigian, C. Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry 33, 2538-2545 (1994).
24. Aeschlimann, D., Kaupp, O. & Paulsson, M. Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: Identification of osteonectin as a major glutaminyl substrate. J. Cell Biol. 129, 881-892 (1995).
25. Kleman, J., Aeschlimann, D., Paulsson, M. & van der Rest, M. Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells. Biochemistry 34, 13768-13775 (1995).
26. Bowness, J.M., Folk, J.E. & Timpl, R.J. Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen. J. Biol. Chem. 262, 1022-1024 (1987).
27. Aeschlimann, D. & Paulsson, M. Cross-linking of laminin-nidogen complexes by tissue transglutaminase. J. Biol. Chem. 266, 15308-15317 (1991).
28. Piacentini, M. Tissue transglutaminase: A candidate effector element of physiological cell death. Curr. Top. Microbiol. Immunol. 200, 163-175 (1995).
29. Knight, C.R.L., Rees, R.C. & Griffin, M. Apoptosis: A potential role for cytosolic transglutaminase and its importance in tumour progression. Biochim. Biophys. Acta 1096, 312-318 (1991).
30. Bruce, S.E., Bjarnason, I. & Peters, T.J. Human jejunal transglutaminase: Demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clin. Sci. 68, 573-579 (1985).
31. Szabolcs, M., Sipka, S. & Csorba, S. In vitro cross-linking of gluten into high-molecular-weight polymers with transglutaminase. Acta Paediatr. Hung. 28, 215-227 (1987).
32. Ladinser, B., Rossipal, E. & Pittschieler, K. Endomysium antibodies in coeliac disease: An improved method. Gut 35, 776-778 (1994).
33. Lundin, K.E.A. et al. Gliadin-specific, HLA-DQ(α1*0501,β1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 178, 187-196 (1993).
34. Lankisch, P.G. et al. Diagnostic intervals for recognizing celiac disease. Z. Gastroenterol. 34, 473-477 (1996).
35. Sosroseno, W. A review of the mechanisms of oral tolerance and immunotherapy. J. R. Soc. Med. 88, 14-17 (1995).
36. Lämmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685 (1970).
37. Schägger, H. & von Jagow, G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 10 kDa. Anal. Biochem. 166, 368-379 (1987).